| ISPVX | NAESX | ISPVX / NAESX | |
| Total Expense Ratio | 0.77 | 0.17 | 453% |
| Annual Report Gross Expense Ratio | 0.95 | 0.17 | 559% |
| Fund Existence | 12 years | 66 years | - |
| Gain YTD | 22.004 | 18.436 | 119% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 386M | 183B | 0% |
| Annual Yield % from dividends | 0.34 | 1.10 | 31% |
| Returns for 1 year | 32.83 | 27.41 | 120% |
| Returns for 3 years | 60.32 | 52.59 | 115% |
| Returns for 5 years | 4.01 | 38.01 | 11% |
| Returns for 10 years | 49.68 | 159.57 | 31% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYOAX | 70.79 | 0.72 | +1.03% |
| Rydex Biotechnology H | |||
| MDLRX | 25.51 | 0.01 | +0.04% |
| BlackRock Advantage Large Cap Core Inv A | |||
| GIEYX | 17.79 | -0.01 | -0.06% |
| GuideStone Funds International Eq Instl | |||
| HRMVX | 34.96 | -0.03 | -0.09% |
| Harbor Mid Cap Value Admin | |||
| VBIAX | 55.15 | -0.09 | -0.16% |
| Vanguard Balanced Index Adm | |||